Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells

Stem Cell Reports

Volumn 8, Issue 5, 2017, Pages 1144-1154

  Monzel, Anna S ^a   Smits, Lisa M ^a   Hemmer, Kathrin ^a   Hachi, Siham ^a   Moreno, Edinson Lucumi ^a   van Wuellen, Thea ^a   Jarazo, Javier ^a   Walter, Jonas ^a   Brüggemann, Inga ^a   Boussaad, Ibrahim ^a   Berger, Emanuel ^a   Fleming, Ronan M T ^a   Bolognin, Silvia ^a   Schwamborn, Jens C ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

midbrain; neural stem cells; organoid; Parkinson's disease; stem cells

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; AQUAPORIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BRAIN PROTEIN; CASPASE 3; DOPAMINE; DOPAMINE TRANSPORTER; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN; MYELIN BASIC PROTEIN; NESTIN; NEUROMELANIN; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN S100B; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PITX3; TRANSCRIPTION FACTOR SOX1; TRANSCRIPTION FACTOR SOX2; TUJ1 PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BRAIN ELECTROPHYSIOLOGY; CELL PROLIFERATION; COMPARATIVE STUDY; CONNECTOME; CONTROLLED STUDY; CYTOPLASM; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; MESENCEPHALON; MYELINATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROEPITHELIUM CELL; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; RHOMBENCEPHALON; SYNAPTIC TRANSMISSION; UPREGULATION; CELL CULTURE; CYTOLOGY; METABOLISM; MYELIN SHEATH; NERVOUS SYSTEM DEVELOPMENT; ORGANOID;

CELLS, CULTURED; DOPAMINERGIC NEURONS; HUMANS; MESENCEPHALON; MYELIN SHEATH; NEURAL STEM CELLS; NEUROEPITHELIAL CELLS; NEUROGENESIS; ORGANOIDS;

EID: 85017459346     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2017.03.010     Document Type: Article

References (36)

1. Baharvand, H., Hashemi, S.M., Kazemi Ashtiani, S., Farrokhi, A., Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int. J. Dev. Biol. 50 (2006), 645–652.
2. Bu, L.L., Yang, K., Xiong, W.X., Liu, F.T., Anderson, B., Wang, Y., Wang, J., Toward precision medicine in Parkinson's disease. Ann. Transl. Med., 4, 2016, 26.
3. Bunk, E.C., Ertaylan, G., Ortega, F., Pavlou, M.A., Gonzalez-Cano, L., Stergiopoulos, A., Safaiyan, S., Vols, S., van Cann, M., Politis, P.K., et al. Prox1 is required for oligodendrocyte cell identity in adult neural stem cells of the subventricular zone. Stem Cells 34 (2016), 2115–2129.
4. Chaboub, L.S., Deneen, B., Astrocyte form and function in the developing central nervous system. Semin. Pediatr. Neurol. 20 (2013), 230–235.
5. Chung, W.S., Welsh, C.A., Barres, B.A., Stevens, B., Do glia drive synaptic and cognitive impairment in disease?. Nat. Neurosci. 18 (2015), 1539–1545.
6. Duan, D., Fu, Y., Paxinos, G., Watson, C., Spatiotemporal expression patterns of Pax6 in the brain of embryonic, newborn, and adult mice. Brain Struct. Funct. 218 (2013), 353–372.
7. Eiraku, M., Sasai, Y., Self-formation of layered neural structures in three-dimensional culture of ES cells. Curr. Opin. Neurobiol. 22 (2012), 768–777.
8. Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., Sasai, Y., Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3 (2008), 519–532.
9. Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., Matrix elasticity directs stem cell lineage specification. Cell 126 (2006), 677–689.
10. Faivre-Sarrailh, C., Devaux, J.J., Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases. Front. Cell. Neurosci., 7, 2013, 196.
11. Garcia-Reitboeck, P., Anichtchik, O., Dalley, J.W., Ninkina, N., Tofaris, G.K., Buchman, V.L., Spillantini, M.G., Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra. Exp. Neurol. 248 (2013), 541–545.
12. Greiner, J., Kaltschmidt, B., Kaltschmidt, C., Widera, D., Going 3D—cell culture approaches for stem cell research and therapy. Curr. Tissue Eng. 2 (2013), 8–19.
13. Hartfield, E.M., Yamasaki-Mann, M., Ribeiro Fernandes, H.J., Vowles, J., James, W.S., Cowley, S.A., Wade-Martins, R., Physiological characterisation of human iPS-derived dopaminergic neurons. PLoS One, 9, 2014, e87388.
14. Hillje, A.L., Schwamborn, J.C., Utilization of stem cells to model Parkinson's disease—current state and future challenges. Future Neurol. 11 (2016), 171–186.
15. Jablonska, B., Aguirre, A., Raymond, M., Szabo, G., Kitabatake, Y., Sailor, K.A., Ming, G.L., Song, H., Gallo, V., Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat. Neurosci. 13 (2010), 541–550.
16. Jo, J., Xiao, Y., Sun, A.X., Cukuroglu, E., Tran, H.D., Goke, J., Tan, Z.Y., Saw, T.Y., Tan, C.P., Lokman, H., et al. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19 (2016), 248–257.
17. Lancaster, M.A., Knoblich, J.A., Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9 (2014), 2329–2340.
18. Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P., Knoblich, J.A., Cerebral organoids model human brain development and microcephaly. Nature 501 (2013), 373–379.
19. Le Grand, J.N., Gonzalez-Cano, L., Pavlou, M.A., Schwamborn, J.C., Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression. Cell Mol. Life Sci. 72 (2014), 773–797.
20. Lee, G.Y., Kenny, P.A., Lee, E.H., Bissell, M.J., Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4 (2007), 359–365.
21. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., Chen, C.S., Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6 (2004), 483–495.
22. Michel, P.P., Hirsch, E.C., Hunot, S., Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90 (2016), 675–691.
23. Molofsky, A.V., Krencik, R., Ullian, E.M., Tsai, H.H., Deneen, B., Richardson, W.D., Barres, B.A., Rowitch, D.H., Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 26 (2012), 891–907.
24. Moreno, E.L., Hachi, S., Hemmer, K., Trietsch, S.J., Baumuratov, A.S., Hankemeier, T., Vulto, P., Schwamborn, J.C., Fleming, R.M., Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture. Lab Chip 15 (2015), 2419–2428.
25. Muguruma, K., Nishiyama, A., Kawakami, H., Hashimoto, K., Sasai, Y., Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep. 10 (2015), 537–550.
26. Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., Sasai, Y., Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10 (2012), 771–785.
27. Qian, X., Nguyen, H.N., Song, M.M., Hadiono, C., Ogden, S.C., Hammack, C., Yao, B., Hamersky, G.R., Jacob, F., Zhong, C., et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165 (2016), 1238–1254.
28. Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C.S., Hoing, S., Moritz, S., Parga, J.A., Wagner, L., Bruder, J.M., et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One, 8, 2013, e59252.
29. Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459 (2009), 262–265.
30. Schwarz, M., Alvarez-Bolado, G., Dressler, G., Urbanek, P., Busslinger, M., Gruss, P., Pax2/5 and Pax6 subdivide the early neural tube into three domains. Mech. Dev. 82 (1999), 29–39.
31. Sepe, S., Milanese, C., Gabriels, S., Derks, K.W., Payan-Gomez, C., van, I.W.F., Rijksen, Y.M., Nigg, A.L., Moreno, S., Cerri, S., et al. Inefficient DNA repair is an aging-related modifier of Parkinson's disease. Cell Rep. 15 (2016), 1866–1875.
32. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
33. Tanaka, H., Murphy, C.L., Murphy, C., Kimura, M., Kawai, S., Polak, J.M., Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone. J. Cell Biochem. 93 (2004), 454–462.
34. Tian, X.F., Heng, B.C., Ge, Z., Lu, K., Rufaihah, A.J., Fan, V.T., Yeo, J.F., Cao, T., Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand. J. Clin. Lab. Invest. 68 (2008), 58–67.
35. Xu, Y., Yang, J., Shang, H., Meta-analysis of risk factors for Parkinson's disease dementia. Transl. Neurodegener., 5, 2016, 11.
36. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007), 1917–1920.